JUSTIN KLEIN

Justin Klein stands as a pivotal figure in the healthcare investment landscape, serving as a Managing Partner at Vensana Capital. At Vensana, a leading venture capital firm dedicated to advancing medical technology, Klein plays a crucial role in identifying, funding, and scaling innovative companies that are poised to transform patient care. His leadership helps guide the firm's strategic direction and investment thesis, focusing on high-potential opportunities within the dynamic healthcare sector.

Klein's investment focus at Vensana Capital is broad yet specialized, encompassing a range of critical areas within medical technology. He actively seeks out companies developing cutting-edge medical devices, advanced diagnostics, and transformative digital health solutions. His portfolio often includes innovations in cardiovascular health, neuromodulation, minimally invasive procedures, and tech-enabled healthcare services. This targeted approach ensures that Vensana Capital supports ventures with the potential for significant clinical impact and market disruption.

Before co-founding Vensana Capital, Klein built an impressive career marked by significant contributions to healthcare venture capital. He previously served as a Partner at New Enterprise Associates (NEA), one of the world's largest and most active venture capital firms. At NEA, he co-led the firm's highly successful healthcare investing practice, overseeing numerous impactful investments. Prior to his tenure at NEA, Klein was instrumental as a co-founder and partner at The Foundry, a renowned medical device incubator responsible for launching several successful companies. His early career also included work at the Cardiovascular Research Foundation, further solidifying his foundational understanding of medical innovation.

Klein's academic background is equally robust, holding an MD from Yale School of Medicine and an MBA from Yale School of Management, alongside a BA from Yale University. This unique blend of medical training and business acumen provides him with a comprehensive perspective, enabling him to thoroughly evaluate both the clinical efficacy and commercial viability of potential investments. He also completed an internal medicine internship at Yale New Haven Hospital, grounding his investment decisions in real-world medical practice.

Throughout his career, Justin Klein has been associated with numerous notable investments that have gone on to achieve significant milestones. These include companies like Shockwave Medical (NASDAQ: SWAV), a pioneer in intravascular lithotripsy, and Relievant Medsystems, focused on chronic lower back pain solutions. Other impactful ventures include Intuity Medical, developing innovative diabetes management systems, and SetPoint Medical, advancing bioelectronic medicine. His involvement often extends to serving on the boards of directors for these companies, providing strategic guidance and leveraging his deep industry network to foster growth and accelerate market adoption. Klein's commitment to fostering innovation and improving patient outcomes continues to make him a highly respected and influential figure in the global healthcare investment community.